Moderna CCP Virus Vaccine Won’t Be Ready Until Spring 2021: CEO

Moderna’s CEO Stéphane Bancel said Wednesday that the U.S. biotech firm’s CCP virus vaccine will most likely not be ready until spring 2020.

A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against COVID-19, in Cambridge, Mass., on May 18, 2020. Brian Snyder/Reuters, File Photo

Moderna CEO Stéphane Bancel said on Sept. 30 that the U.S. biotech firm’s CCP virus vaccine most likely won’t be ready for widespread public distribution until spring 2021.

The Massachusetts-based company also won’t be ready to apply for emergency authorization for its potential vaccine until Nov. 25 at the earliest, Bancel told the Financial Times.